Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
07/2003
07/23/2003EP1328642A2 Gene 4
07/23/2003EP1328639A2 Carotenoid production by recombinant, c1-metabolizing methanotrophic bacteria
07/23/2003EP1328631A2 Her-2/neu fusion proteins
07/23/2003EP1328629A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
07/23/2003EP1328623A2 Human proteases and polynucleotides encoding the same
07/23/2003EP1328622A2 Protein c or activated protein c-like molecules
07/23/2003EP1328621A2 13245, a novel human myotonic dystrophy type protein kinase and uses therefor
07/23/2003EP1328614A1 Catalase as an oxidative stabilizer in solid particles and granules
07/23/2003EP1328551A2 An acyl coenzyme a carboxylase from streptomyces
07/23/2003EP1140199B1 Hyaluronate lyase used for promoting penetration in topical agents
07/23/2003EP1029040B1 Method of increasing efficiency of directed evolution of a gene using phagemid
07/23/2003EP0743958B1 Avidin-biotin immunoconjugates
07/23/2003EP0714408B1 Tryptase inhibitor
07/23/2003EP0658203B1 Modified fungal cells and method for producing recombinant products
07/23/2003CN1432058A Redeposition or backstain inhibition during stonewashing process
07/23/2003CN1431907A Method of treating hepatitis delta viral infection
07/23/2003CN1431302A Method for preparing tablets of immobilization choline esterase
07/23/2003CN1431301A Method for preparing selenium substitution papain
07/23/2003CN1115412C Pro-Urokinase mutants
07/22/2003USRE38202 Antibodies specific for a haemostatic protein, their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
07/22/2003US6596928 Plants synthesizing a modified starch, the generation of the plants, their use, and the modified starch
07/22/2003US6596927 Genes coding for flavone synthases
07/22/2003US6596926 Isolated polynucleotide comprising nucleotide sequence encoding a polypeptide having phosphatidylethanolamine N-methyltransferase activity
07/22/2003US6596925 Compositions and methods for the modification of gene expression
07/22/2003US6596923 Methods and compositions to identify swine genetically resistant to F18 E. coli associated diseases
07/22/2003US6596851 Antibody for use in the treatment of cell proliferative disorders
07/22/2003US6596848 Antibodies to NIMA interacting proteins
07/22/2003US6596735 Compounds and to the use of said compounds for inhibiting abnormal cell growth in mammals. The compounds of the above formula have activity as farnesyl protein transferase inhibitors. for treatment of cancer andhyperproliferation
07/22/2003US6596694 Caloporoside derivatives, methods of their preparation and use
07/22/2003US6596538 Expression vector coding enzymatic polypeptide for use in the preparation of cosmetics, detergents, plastics and lubricants
07/22/2003US6596533 Polypeptide for use in the treatment of infections and cell proliferative disorders
07/22/2003US6596528 Heat-stable D-aminoacylase
07/22/2003US6596527 Nucleotide sequences coding enzymatic polypeptide for use in the diagnosis and treatment of liver disorders
07/22/2003US6596526 Furin polypeptides with improved characteristics
07/22/2003US6596525 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
07/22/2003US6596524 Method for cloning and expression of BsmAi restriction endonuclease and BsmAI methylase in E. coli
07/22/2003US6596523 Sialyltransferase for use in the diagnosis and treatment of inflammation and cancer
07/22/2003US6596520 Immobilizing lipase by adsorption from a crude solution onto nonpolar polyolefin particles
07/22/2003US6596516 Process for the fermentative preparation of L-amino acids using coryneform bacteria
07/22/2003US6596514 Nucleotide sequences which can improve expression of recombinant proteins two- to eight-fold in stable cell pools when present in an expression vector
07/22/2003US6596513 DNA sequence possessing regulated transcriptional promoter activity in two directions; expression vectors; use for the production of recombinant proteins from either homologous or heterologous sources
07/22/2003US6596494 Methods for using mutant RNA polymerases with reduced discrimination between non-canonical and canonical nucleoside triphosphates
07/22/2003US6596491 Tenascin-C nucleic acid ligands
07/22/2003US6596485 Fusion proteins capapble of presenting the peptide in a conformationally restricted form; use in screening peptide libraries
07/22/2003US6596172 Purification of biological substances
07/22/2003CA2033085C Use of vaccine preparations containing adenyl cyclase or adenyl cyclase producing bacteria as protecting antigens against bordetella effects
07/17/2003WO2003057887A1 Novel udp-n-acetyl-d-galactosamine:polypeptide n-acetylgalactosamine transferases and nucleic acids encoding the same
07/17/2003WO2003057886A2 Detection of mutations
07/17/2003WO2003057879A1 Novel udp-n-acetyl-d-galactosamine:polypeptide n-acetylgalactosamine transferase and nucleic acid encoding the same
07/17/2003WO2003057876A1 Method of screening multiple squamous carcinoma risk group
07/17/2003WO2003057874A1 Disease markers for renal diseaes and utilization thereof
07/17/2003WO2003057871A1 Enzymes coated with ionic liquid
07/17/2003WO2003057870A1 Human phosphatidic acid phosphatase type 2-like protein
07/17/2003WO2003057869A1 Regulation of human sulfatase
07/17/2003WO2003057868A1 Novel n-acetylglucosamines transferase and nucleic acids encoding the same
07/17/2003WO2003057867A2 Regulation of human fatty acid coa ligase-like amp-binding enzyme
07/17/2003WO2003057859A2 Genes for altering mitochondrial function and for hybrid seed production
07/17/2003WO2003057854A2 Novel proteins and nucleic acids encoding same
07/17/2003WO2003057853A2 Oxidative stress-resistant cell lines and methods of use thereof
07/17/2003WO2003057842A2 Aggrecanase molecules
07/17/2003WO2003057841A2 Remote homologues and kinases and methods of detection
07/17/2003WO2003057835A2 Pak5-related compositions and methods
07/17/2003WO2003057831A2 Dtat fusion toxin
07/17/2003WO2003057830A2 Compositions and methods for hydroxylating epothilones
07/17/2003WO2003057828A2 Method of producing glycoproteins having reduced complex carbohydrates in mammalian cells
07/17/2003WO2003057826A2 SOLUBLE GLcNAC PHOSPHOTRANSFERASE
07/17/2003WO2003057721A2 Substituted amino carboxamides for the treatment of alzheimer's disease
07/17/2003WO2003057713A2 Proteases producing an altered immunogenic response and methods of making and using the same
07/17/2003WO2003057710A2 Methods of producing high mannose glycoproteins in complex carbohydrate deficient cells
07/17/2003WO2003057248A1 Thermotolerant phytase for animal feed
07/17/2003WO2003057247A1 Microbially-expressed thermotolerant phytase for animal feed
07/17/2003WO2003057246A1 Proteases producing an altered immunological response and methods of making and using the same
07/17/2003WO2003057238A1 Agents that recognize src when phosphorylated at serine 17
07/17/2003WO2003057204A2 Modulation of iamt (pimt or pcmt) in immune system
07/17/2003WO2003057173A2 Broad spectrum inhibitors
07/17/2003WO2003057138A2 Expression of lysosomal hydrolase in cells expressing pro-n-acetylglucosamine-1-phosphodiester alpha-n-acetyl glucosimanidase
07/17/2003WO2003056914A1 Methods to engineer mammalian-type carbohydrate structures
07/17/2003WO2003056912A2 Inducible transposition in transgenic organism using transposon vector
07/17/2003WO2003056897A2 Highly phosphorylated acid beta-glucocerebrosidase and methods of treating gaucher's disease
07/17/2003WO2003045907A3 Sir2 products and activities
07/17/2003WO2003039243A3 Amine oxidase stress-related polypeptides and methods of use in plants
07/17/2003WO2003004595A3 Materials and methods relating to protein and nucleic acid evolution
07/17/2003WO2002081646A3 Epitope sequences
07/17/2003WO2002077233A8 38650, 28472, 5495, 65507, 81588 and 14354 METHODS AND COMPOSITIONS OF HUMAN PROTEINS AND USES THEREOF
07/17/2003WO2002072626A3 Novel form of the phgpx protein as a diagnostic marker for male infertility
07/17/2003WO2002059286A3 Adenylate cyclases
07/17/2003WO2002058323A3 Method for identifying modulators of bace
07/17/2003WO2002040683A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/17/2003WO2002032962A3 Compositions of human proteins and method of use thereof
07/17/2003WO2002031134A3 Novel serine protease genes related to dppiv
07/17/2003WO2002026998A3 Hydrolases
07/17/2003WO2001070943A3 Stable composition comprising a nuclease and a phosphatase
07/17/2003US20030135888 Nucleotide sequences for controlling expression of RNA sequences in rice plants; antisense agents; genetic suppressor sequences
07/17/2003US20030135887 Plant bioreactors
07/17/2003US20030135885 Self-processing plants and plant parts
07/17/2003US20030135883 Synthases/polypeptides for altering concentration or morphology of glucans/polysaccharide/amylose in plants; gene expression inhibition; genetic mapping
07/17/2003US20030135879 Methods and materials for making and using transgenic dicamba-degrading organisms
07/17/2003US20030135878 Transgenic plants with elevated thioredoxin levels
07/17/2003US20030135871 Modified railroad worm red luciferase coding sequences
07/17/2003US20030135035 Human ZZAP1 protein
1 ... 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 ... 1416